Memorial Sloan Kettering Cancer Center collaboration advances
Written by Camila Cepero on February 28, 2017
Memorial Sloan Kettering Cancer Center and the Miami Cancer Institute have begun a collaboration aimed at improving patient access to the latest and most effective cancer treatment advances – a mission that includes the launch of future collaborative clinical trials between both institutions.
Leaders from both institutions have confirmed the first step in announcing their recently signed agreement for the Miami Cancer Institute to join the Memorial Sloan Kettering Cancer Alliance, a partnership between Memorial Sloan Kettering Cancer Center and community oncology providers that seeks to bring the most current knowledge and advanced cancer care into the community setting, according to the Miami Cancer Institute’s website.
At any given time, according to Memorial Sloan Kettering Cancer Center, hundreds of clinical trials are being conducted to improve care for many types of cancer.
An essential component of this alliance is the ability to provide access to clinical trials not previously available to patients in the Miami area.
“We want to look down their list of hundreds of trials and look at which are the most appropriate for us and our community,” said Miami Cancer Institute founding CEO and Executive Medical Director Michael Zinner.
Miami Cancer Institute, which opened its doors last month, will also be conducting trials independent from Sloan Kettering.
South Florida’s melting pot of people from around the world makes it a “positive target for those who want access to conduct clinical trials,” Dr. Zinner said.
“This first year will be a commitment to making sure that the institution works – that the lights go on, that the power goes on, that the registration system works,” he said, “and at the same time building our clinical trials program.”
The program currently has 30 employees, with plans of expanding to 50 over the next year.
“Research and clinical trials is a very important part of what Miami Cancer Institute will be of,” Dr. Zinner said.
Over the next few months, Memorial Sloan Kettering Cancer Center will collaboratively guide Miami Cancer Institute toward strengthening its patient care and clinical cancer research programs. Teams of physicians and other healthcare providers from both institutions are to work diligently side by side for hundreds of hours to ensure that resources, capabilities and standards of care are in line with the highest and most recent standards of the Memorial Sloan Kettering Cancer Alliance, officials say.
Once this first phase is complete, Miami Cancer Institute is expected to become an official member of the Memorial Sloan Kettering Cancer Alliance over the next year.